Nanjing Medlander Medical Technology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005PV8
CNY
35.19
5.15 (17.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
419.81
335.88
372.64
336.71
331.62
252.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
419.81
335.88
372.64
336.71
331.62
252.11
Raw Material Cost
136.06
108.09
127.69
99.83
85.51
52.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
128.95
114.63
114.70
98.47
84.38
62.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.09
0.45
0.35
0.19
0.50
0.31
Selling and Distribution Expenses
137.02
122.40
112.75
96.91
89.29
75.71
Other Expenses
-7.60
-6.04
-7.58
-6.30
-4.51
-3.77
Total Expenditure (Excl Depreciation)
327.08
285.20
279.65
232.43
214.62
153.30
Operating Profit (PBDIT) excl Other Income
92.69999999999999
50.7
93
104.3
117
98.80000000000001
Other Income
33.02
36.04
42.09
16.59
7.46
5.62
Operating Profit (PBDIT)
164.86
121.75
163.78
142.98
144.81
118.53
Interest
1.09
0.45
0.35
0.19
0.50
0.31
Exceptional Items
-8.78
0.66
0.03
0.01
0.01
0.00
Gross Profit (PBDT)
283.75
227.79
244.95
236.89
246.11
199.35
Depreciation
29.01
20.13
17.61
13.10
7.22
3.28
Profit Before Tax
126.00
101.82
145.85
129.70
137.09
114.94
Tax
16.23
9.00
16.61
10.04
16.57
10.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
101.58
89.82
121.68
118.38
121.93
106.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
101.58
89.82
121.68
118.38
121.93
106.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.32
2.67
7.60
1.31
-0.58
-0.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
108.90
92.48
129.29
119.70
121.36
105.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,312.20
1,345.78
1,350.18
363.50
240.42
153.81
Earnings per share (EPS)
1.02
0.89
1.22
1.18
1.22
1.06
Diluted Earnings per share
1.02
0.89
1.22
1.18
1.22
1.06
Operating Profit Margin (Excl OI)
24.5%
19.52%
27.93%
33.65%
39.24%
43.48%
Gross Profit Margin
36.92%
36.31%
43.87%
42.41%
43.52%
46.89%
PAT Margin
24.2%
26.74%
32.65%
35.16%
36.77%
42.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 24.98% vs -9.85% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 17.73% vs -28.46% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 53.79% vs -29.58% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 120.00% vs 66.67% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Nanjing Medlander Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
419.81
0
419.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
419.81
0
419.81
Raw Material Cost
136.06
0
136.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
128.95
0
128.95
Power Cost
0
0
0.00
Manufacturing Expenses
1.09
0
1.09
Selling and Distribution Expenses
137.02
0
137.02
Other Expenses
-7.60
0.00
-7.60
Total Expenditure (Excl Depreciation)
327.08
0
327.08
Operating Profit (PBDIT) excl Other Income
92.73
0.00
92.73
Other Income
33.02
0
33.02
Operating Profit (PBDIT)
164.86
0
164.86
Interest
1.09
0
1.09
Exceptional Items
-8.78
0
-8.78
Gross Profit (PBDT)
283.75
0
283.75
Depreciation
29.01
0
29.01
Profit Before Tax
126.00
0
126.00
Tax
16.23
0
16.23
Provisions and contingencies
0
0
0.00
Profit After Tax
101.58
0
101.58
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
101.58
0
101.58
Share in Profit of Associates
0
0
0.00
Minority Interest
7.32
0
7.32
Other related items
0.00
0.00
0.00
Consolidated Net Profit
108.90
0
108.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,312.20
0
1,312.20
Earnings per share (EPS)
1.02
0
1.02
Diluted Earnings per share
1.02
0
1.02
Operating Profit Margin (Excl OI)
24.50%
0%
0.00
24.50%
Gross Profit Margin
36.92%
0%
0.00
36.92%
PAT Margin
24.20%
0%
0.00
24.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 41.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 24.98% vs -9.85% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 10.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 17.73% vs -28.46% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 53.79% vs -29.58% in Dec 2023

Annual - Interest
Interest 0.11 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 120.00% vs 66.67% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.50%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023